Are RAS mutations predictive markers of resistance to standard chemotherapy? (Q37549918)

21 August 2017

1 reference

title

Are RAS mutations predictive markers of resistance to standard chemotherapy? (English)

1 reference

21 August 2017

1 reference

5

Jean-Charles Soria

0 references

author name string

Yohann Loriot

1

1 reference

21 August 2017

Pierre Mordant

2

1 reference

21 August 2017

Eric Deutsch

3

1 reference

21 August 2017

Ken André Olaussen

4

1 reference

21 August 2017

language of work or name

English

0 references

publication date

14 July 2009

1 reference

Nature Reviews Clinical Oncology

21 August 2017

published in

1 reference

21 August 2017

volume

6

1 reference

21 August 2017

issue

9

1 reference

21 August 2017

page(s)

528-534

1 reference

Resistance to anticancer drugs in NIH3T3 cells transfected with c-myc and/or c-H-ras genes

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.106

Involvement of the Ras/extracellular signal-regulated kinase signalling pathway in the regulation of ERCC-1 mRNA levels by insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.106

p16INK4a expression and absence of activated B-RAF are independent predictors of chemosensitivity in melanoma tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.106

The role of chemotherapy in biliary tract carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.106

Hyperactive Ras in developmental disorders and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.106

Mutational activation of the K-ras oncogene and the effect of chemotherapy in advanced adenocarcinoma of the lung: a prospective study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.106

Prognostic and Therapeutic Implications of EGFR and KRAS Mutations in Resected Lung Adenocarcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.106

The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.106

Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.106

KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.106

Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.106

K-ras mutations and benefit from cetuximab in advanced colorectal cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.106

Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.106

Correlation of intrinsic chemoresistance of non-small-cell lung cancer cell lines with HER-2/neu gene expression but not with ras gene mutations.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.106

The resurgence of platinum-based cancer chemotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.106

Modulation of activity of the promoter of the human MDR1 gene by Ras and p53.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.106

H-ras transfection in mink lung epithelial cells may induce “atypical” multidrug resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.106

Ability to Acquire Drug Resistance Arises Early during the Tumorigenesis Process

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.106

Cell specificity and an effect of ras on human metallothionein gene expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.106

Insulin and glucose regulate the expression of the DNA repair enzyme XPD

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.106

v-Ha-ras oncogene insertion: a model for tumor progression of human small cell lung cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.106

Effect of v-rasH on sensitivity of NCI-H82 human small cell lung cancer cells to cisplatin, etoposide, and camptothecin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.106

Mutated K-ras gene analysis in a randomized trial of preoperative chemotherapy plus surgery versus surgery in stage IIIA non-small cell lung cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.106

Lack of prognostic significance of p53 and K-ras mutations in primary resected non-small-cell lung cancer on E4592: a Laboratory Ancillary Study on an Eastern Cooperative Oncology Group Prospective Randomized Trial of Postoperative Adjuvant Therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.106

Prognostic and predictive importance of p53 and RAS for adjuvant chemotherapy in non small-cell lung cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.106

5-Fluorouracil: mechanisms of action and clinical strategies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.106

Oncogenic Ras increases sensitivity of colon cancer cells to 5-FU-induced apoptosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.106

Ha-ras overexpression mediated cell apoptosis in the presence of 5-fluorouracil

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.106

Ribozyme-mediated cleavage of c-fos mRNA reduces gene expression of DNA synthesis enzymes and metallothionein

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.106

DNA topoisomerase I--targeted chemotherapy of human colon cancer in xenografts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.106

Prognostic significance of K-ras and TP53 mutations in the role of adjuvant chemotherapy on survival in patients with Dukes C colon cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.106

Determination of TP53 mutation is more relevant than microsatellite instability status for the prediction of disease-free survival in adjuvant-treated stage III colon cancer patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.106

K-Ras mutations and treatment outcome in colorectal cancer patients receiving exclusive fluoropyrimidine therapy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.106

Irinotecan hydrochloride (CPT-11) resistance identified by K-ras mutation in patients with progressive colon cancer after treatment with 5-fluorouracil (5-FU).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.106

Ki-ras mutation type and the survival benefit from adjuvant chemotherapy in Dukes' C colorectal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.106

Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.106

Molecular alterations associated with improved survival in pancreatic cancer patients treated with radiation or chemotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.106

K-ras mutation in the endometrium of tamoxifen-treated breast cancer patients, with a comparison of tamoxifen and toremifene

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.106

Endometrial K-ras mutations in postmenopausal breast cancer patients treated with adjuvant tamoxifen or toremifene

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.106

Gallbladder cancer: lessons from a rare tumour

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.106

Association of k-ras, b-raf, and p53 status with the treatment effect of bevacizumab

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.106

Determination of microsatellite instability, p53 and K-RAS mutations in hepatic metastases from patients with colorectal cancer: relationship with response to 5-fluorouracil and survival

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.106

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.106

Interpretation of microarray data in cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.106

Regrowth of 5-fluorouracil-treated human colon cancer cells is prevented by the combination of interferon gamma, indomethacin, and phenylbutyrate.

31 March 2020

1 reference

12 December 2020

Mutant K-ras oncogenes in colon cancers Do not predict Patient's chemotherapy response or survival

1 reference

12 December 2020

Lovastatin augments apoptosis induced by chemotherapeutic agents in colon cancer cells

1 reference

12 December 2020

Expression of the c-Ha-ras oncogene in mouse NIH 3T3 cells induces resistance to cisplatin

1 reference

12 December 2020

Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: a Southwest Oncology Group study.

1 reference

12 December 2020

Inhibition of apoptosis after thymineless stress is conferred by oncogenic K-Ras in colon carcinoma cells

1 reference

12 December 2020

10.1038/NRCLINONC.2009.106

Identifiers

DOI

1 reference

21 August 2017

1 reference